HNRNPA1 and prostate carcinoma: Since hnRNPA1 is a MNK effector [36], and is inhibited by Quercetin in prostate cancer cells [29], we evaluated whether hnRNPA1 knockdown also enhances the anti-tumor effects of BET inhibitors.